SCHEMBL2467885

SCHEMBL2467885

O=C(NCc1ccc(Oc2ccccc2)cc1)c1ccc(-c2nc(CN(C(=O)c3ccc(C(F)(F)F)cc3)c3ccc(O)c(C(=O)O)c3)cs2)cc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 4/20 0.52
MAPK14 Q16539 3/20 0.51
RHOC P08134 1/20 0.43
RHOA P61586 1/20 0.43
TP53 P04637 3/20 0.42
PPARA Q07869 2/20 0.42
MAPT P10636 2/20 0.42
LMNA P02545 2/20 0.42
PPARG P37231 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
EIF4E P06730 1/20 0.42
PDK1 Q15118 1/20 0.42
POLB P06746 1/20 0.41
KLKB1 P03952 1/20 0.41
CYP3A4 P08684 1/20 0.41
HTT P42858 1/20 0.41
MMP13 P45452 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2467356 0.94 STAT3 (0.56) STAT3MAPK14PPARALMNAEIF4E
SCHEMBL14208388 0.89 STAT3 (0.49) STAT3MAPK14PPARALMNAEIF4E
SCHEMBL2468218 0.88 STAT3 (0.67) STAT3MAPK14LMNAMEN1KMT2A
SCHEMBL2469349 0.87 STAT3 (0.52) STAT3RHOCRHOATP53MAPT
SCHEMBL2472578 0.86 STAT3 (0.53) STAT3MAPK14LMNAMEN1KMT2A
SCHEMBL2468824 0.86 STAT3 (0.46) STAT3MAPK14PPARALMNAEIF4E
SCHEMBL2469846 0.84 STAT3 (0.48) STAT3MAPK14PPARALMNAEIF4E
SCHEMBL2471982 0.81 STAT3 (0.74) STAT3MAPK14PPARALMNAPPARG
SCHEMBL5100796 0.79 MAPK14 (0.55) MAPK14RHOCRHOATP53PPARA
SCHEMBL2469099 0.78 STAT3 (0.57) STAT3MAPK14MAPTLMNAPDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1656139-B1 ARYL DICARBOXAMIDES MERCK SERONO SA (CH) 2011-10-05 EP claimed
US-7365225-B2 Aryl dicarboxamides LABORATOIRES SERONO SA (CH) 2008-04-29 US claimed
US-20060189583-A1 Aryl dicarboxamides MERCK SERONO SA (CH) 2006-08-24 US claimed
EP-1656139-B1 ARYL DICARBOXAMIDES MERCK SERONO SA (CH) 2011-10-05 EP disclosed
US-7365225-B2 Aryl dicarboxamides LABORATOIRES SERONO SA (CH) 2008-04-29 US disclosed
US-7365225-B2 Aryl dicarboxamides LABORATOIRES SERONO SA (CH) 2008-04-29 US disclosed
US-7365225-B2 Aryl dicarboxamides LABORATOIRES SERONO SA (CH) 2008-04-29 US disclosed
US-20060189583-A1 Aryl dicarboxamides MERCK SERONO SA (CH) 2006-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189583-A1 Aryl dicarboxamides GPR119, PTPRS, ECHS1 STAT3 3402/4885MAPK14 3299/4885RHOC 3988/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.